Clinical trial Recruiting at 2 sites Observational Ages 18 and up

Exhaled breath condensate analysis in mechanically ventilated ICU patients

Official title: Proteomic Analysis of Exhaled Breath Condensate in Mechanically Ventilated Intensive Care Patients

Run by The Institute of Molecular and Translational Medicine, Czech Republic · NCT06189924 · Data updated 2026-11-12

This project will collect small samples of exhaled breath condensate and blood from mechanically ventilated ICU patients to see if protein and molecular patterns can signal early lung or other organ problems.

More Acute Respiratory Failure trials

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment200 (estimated)
SponsorThe Institute of Molecular and Translational Medicine, Czech Republic
Academic / other
Locations2 sites (Olomouc and 1 other locations)
StatusRecruiting
StartedMarch 1, 2026
Main results expectedDecember 31, 2028
Study endsDecember 31, 2029
Registry record updatedJune 25, 2026
Trial IDNCT06189924 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are intensive care patients receiving mechanical ventilation whose ventilator circuit is technically suitable for safe EBC sampling.

Probably not a fit

Patients whose ventilation is so unstable that inserting a sampling kit would risk respiratory deterioration, or whose circuits cannot be sampled, are unlikely to benefit from participation.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Researchers will collect tiny amounts of exhaled breath condensate (EBC) from the ventilator circuit and paired venous blood samples from mechanically ventilated intensive care patients. EBC will undergo proteomic analysis by mass spectrometry while blood will be profiled for DNA, RNA, proteins, and metabolites. The team will standardize a sampling method that does not alter ventilation parameters and will freeze and process samples for molecular analysis. Resulting molecular profiles will be correlated with routine clinical and ventilation data to identify patterns that appear at early stages of lung or systemic pathology.

Why it matters

Potential benefit: If successful, this approach could enable earlier detection of lung and other organ problems, potentially shortening mechanical ventilation and ICU stays and reducing complications.

How similar studies have gone: Small pilot studies of exhaled breath condensate and related breath-based proteomic approaches have shown promise, but the method remains largely exploratory and not yet widely validated.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

Intensive care setting Mechanical ventilation Ventilator/ventilator circuit technically suitable for sampling of exhaled breath condensate

Exclusion Criteria:

Mechanical ventilation challenging to the extent that the insertion of the sampling kit into the ventilator circuit would substantially increase the risk for respiratory deterioration

Where it's running

  • Institute of Molecular and Translational Medicine, Palacky University
    Olomouc, Czechia
    Recruiting
  • University Hospital Olomouc
    Olomouc, Czechia
    Recruiting

Study contacts

  • Principal investigator: Emil Berta, MD PhD — IMTM, Palacky University in Olomouc, Faculty of Medicine and Dentistry
  • Study coordinator: Emil Berta, MD PhD
  • Email: e.berta@upol.cz
  • Phone: +420585632111

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.